Experts Rename 1-in-8 Women's Disorder PMOS After 14-Year Push
Updated
Updated · The Philadelphia Inquirer · Jul 5
Experts Rename 1-in-8 Women's Disorder PMOS After 14-Year Push
1 articles · Updated · The Philadelphia Inquirer · Jul 5
Summary
Polyendocrine metabolic ovarian syndrome, or PMOS, was adopted in May by an international expert group to replace PCOS, a term doctors said wrongly implied ovarian cysts and understated the disorder’s body-wide effects.
Anuja Dokras of Penn Medicine said the old name confused patients about fertility and ovarian risks, even though the condition is the most common endocrine disorder in women and carries cardiometabolic and mental-health risks.
14 years of work — beginning after a 2012 NIH meeting — included global surveys of patients and clinicians, with organizers seeking a clearer, less stigmatizing name that still preserved some continuity with PCOS.
A roughly 3-year transition still lies ahead to reclassify PMOS as an endocrine condition, update research literature and electronic records, and change insurance billing codes.
Dokras said the broader name could speed diagnosis, draw more specialties into care, and widen research funding beyond women’s health to diabetes, heart disease, dermatology and mental health.
The PCOS name change highlights metabolic risks. Could this rebranding prevent costly diseases like diabetes and heart disease for millions of women worldwide?
With PCOS now called PMOS, what tangible benefits will patients see when treatments remain unchanged and off-label?
From PCOS to PMOS: The Worldwide Transition to Polyendocrine Metabolic Ovarian Syndrome and Its Impact on Care, Research, and Equity
Overview
The condition once called Polycystic Ovary Syndrome (PCOS) has been officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS). Experts pushed for this change because the old name focused too much on ovarian cysts, which are not always present and are not the main feature of the disorder. The new name, PMOS, better reflects the complex nature of the condition, which involves multiple hormones and often includes metabolic problems. This shift aims to help the medical community see PMOS as a multi-system disorder, leading to more accurate diagnosis and improved care for those affected.